Last checked at (Sharecast News) - Hikma Pharmatheuticals: Citigroup downgrades to neutral with a target price of 1,980p.
Jupiter Fund Management: Berenberg reiterates hold with a target price of 367p.
Centamin: Berenberg reiterates hold with a target price of 127p.
Hummingbird Resources: Berenberg reiterates buy with a target price of 38p.
MJ Gleeson: Canaccord reiterates hold with a target price of 960p.
Imperial Brands: Deutsche Bank reiterates buy with a target price of 2,400p.
National Grid: Barclays reiterates overweight with a target price of 1,115p.
Segro: Deutsche Bank downgrades to hold with a target price of 810p.
AstraZeneca: UBS reiterates sell with a target price of 5,800p.
Just Eat: Barclays reiterates overweight with a target price 8,500p.
Reckitt Benckiser Group: JP Morgan reiterates overweight with a target price of 8,500p.
Royal Bank of Scotland: JP Morgan reiterates overweight with a target price of 260p.
Ashtead: JP Morgan reiterates overweight with a target price of 3,250p.
Dunelm: RBC reiterates sector performer with a target price of 1,250p.
RELX: UBS reiterates sell with a target price of 1,825p.
Barclays: UBS reiterates buy with a target price of 205p.
Associated British Foods: UBS reiterates buy with a target price of 3,200p.
Meggitt: Citigroup downgrades to neutral with a target price of 730p.
19 Jan 2022 08:29
Centamin ends year in line with production forecasts
(Sharecast News) - Centamin reported annual gold production in line with expectations in its fourth quarter update on Wednesday, with 107,549 ounces produced in the three months ended 31 December, making for a 2021 total of 415,370 ounces for 2021, at the midpoint of its guidance.
Read more